MCK

#115
McKesson Corporation
986.8200
+1.65%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
978.5000
986.8300
Годовой диапазон
789.9600
975.2900
Дневное изменение
+1.65%
Месячное изменение
+18.34%
6-месячное изменение
+22.97%
Годовое изменение
+22.97%
Предыдущее закрытие
970.8400
Open
978.5000
Bid
Ask
Low
978.5000
High
986.8300
Объем
510
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization 121.5762 B
  • Employee 51 K
  • Founded N/A
  • CEO Brian S. Tyler
  • Website www.mckesson.com
  • Headquarter Delaware, United States
  • FIGI BBG000DYGNW7
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.17
Price to sales ratio
0.24
Dividends per share
2.75
Dividend yield %
0.41

McKesson Corporation

McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.

Новости